Abbott Laboratories CEO Robert Ford took the stage at the HLTH conference in Las Vegas on Tuesday to discuss the company's expansion into a new market: consumer wearables.
For instance, Abbott produces a continuous glucose monitor (CGM) called FreeStyle Libre that patients can use to manage their diabetes.
Abbott's most recent model, the FreeStyle Libre 3, can measure glucose levels in real time for up to 14 days.
FreeStyle Libre alone generated more than $1.3 billion in sales for Abbott during its second quarter, according to the company's earnings report.
"We always believed that we could take this platform that we developed for diabetes and expand it beyond diabetes," Ford said.
Persons:
Robert B, Ford, Robert Ford, Abbott, Covid, Margaret Kaczor Andrew, William Blair, CNBC's Erin Black, Lingo
Organizations:
Abbott, Libre, wearables
Locations:
Vegas, Las Vegas , Nevada, Las Vegas, U.S